首页|基于多模态MRI探讨参芪益智颗粒对高原地区前驱期阿尔茨海默病患者的疗效观测

基于多模态MRI探讨参芪益智颗粒对高原地区前驱期阿尔茨海默病患者的疗效观测

扫码查看
目的 基于多模态磁共振成像技术探讨参芪益智颗粒对低氧环境下前驱期阿尔茨海默病(pAD)脑结构和功能的影响。方法 选择久居青海地区符合pAD纳入标准,年龄50~85岁、文化程度≥6年、汉族女性患者77例作为受试者。随机分为药物组(参芪益智颗粒)39例,对照组(安慰剂)38例进行临床观察24周。采集受试者临床信息、认知及神经心理测评和扩散张量成像(DTI)、静息态功能磁共振成像(rs-fMRI)。结果 认知及神经心理结果显示,药物组患者MoCA、AVTL、SDMT、CFT-copy得分明显高于治疗前,ADAS-cog和GDS得分显著低于治疗前(P<0。05);对照组ADAS-cog得分明显高于治疗前(P<0。001);治疗后药物组MoCA、AVTL得分高于对照组(P<0。05),ADAS-cog得分低于对照组(P<0。01)。DTI结果显示,治疗后药物组多个脑区的轴向扩散系数升高(P<0。05)。rs-fMRI结果显示,治疗后药物组右侧颞极:颞中回、三角部额下回、内侧和旁扣带回ALFF值升高,左侧小脑半球Crus1小叶、枕上回和缘上回ALFF值降低,药物组右侧背外侧额上回ALFF值较对照组升高(P<0。05)。治疗后药物组左侧三角部额下回和枕下回ReHo值升高,右侧小脑半球Crus1小叶下降(P<0。05),药物组左侧顶下缘角回ReHo较对照组升高(P<0。05)。结论 参芪益智颗粒通过调节认知相关脑区的白质微观结构和自发神经元活动,能够有效改善高原地区pAD总体认知和多认知域功能。
Therapeutic effect of Shenqi Yizhi Granules on prodromal Alzheimer disease in plateau areas:A study based on multimodal magnetic resonance imaging
Objective To investigate the effect of Shenqi Yizhi Granules on brain structure and function in prodromal Alzheimer disease(pAD)under hypoxic conditions based on MRI.Methods A total of 77 female Han Chinese patients,aged 50‒85 years,who had at least 6 years of education and long-term residence in Qinghai region and met the inclusion criteria for pAD were enrolled as subjects.They were randomly divided into drug group(39 patients receiving Shenqi Yizhi Granules)and control group(38 patients receiving placebo)for 24 weeks of clinical observation.Related data were collected from all subjects,including clinical information,cognitive and neuropsychological assessments,diffusion tensor imaging(DTI)data,and rs-fMRI data.Results Cognitive and neuropsychological assessments showed that after treatment,the drug group had significant increases in MoCA,AVTL,SDMT,and CFT-copy scores and significant reductions in ADAS-cog and GDS scores(P<0.05),while the control group had a significantly increase in ADAS-cog score(P<0.001);compared with the control group after treatment,the drug group had significantly higher MoCA and AVTL scores(P<0.05)and a significantly lower ADAS-cog score(P<0.01).DTI results showed that the drug group had significant increases in axial diffusivity(AD)values of multiple brain regions after treatment(P<0.05).The results of rs-fMRI showed that after treatment,the drug group had significant increases in the amplitude of low-frequency fluctuation(ALFF)in the right temporal middle gyrus,the triangular part of the inferior frontal gyrus,and the medial cingulate gyrus and paracingulate gyrus and significant reductions in ALFF in the left cerebellar hemisphere Crus1 lobule,superior occipital gyrus,and supramarginal gyrus,and compared with the control group,the drug group had a significant increase in ALFF in the right dorsolateral superior frontal gyrus(P<0.05).After treatment,the drug group had significant increases in the regional homogeneity(ReHo)values of the left triangular part of the inferior frontal gyrus and the inferior occipital gyrus and a significant reduction in the ReHo value of the left cerebellar hemisphere Crus1 lobule(P<0.05),and compared with the control group,the drug group had a significant increase in the ReHo value of the left inferior parietal gyrus(P<0.05).Conclusion Shenqi Yizhi Granules can effectively improve overall cognition and the function of multiple cognitive domains in pAD patients living in plateau regions by modulating the microstructure of white matter and spontaneous neuronal activity in cognitive-related brain regions.

Multimodal magnetic resonance imagingShenqi Yizhi GranulesProdromal Alzheimer diseasePlateau areaMultidimensional cognition

茹宝根、刘文增、杨国财、钟欣、李梓赟、刘金昊、张永海、朱爱琴

展开 >

青海省人民医院老年医学科,青海 西宁 810000

青海大学研究生院,青海 西宁 810000

青海省人民医院影像中心,青海 西宁 810000

青海省老年疾病临床研究中心,青海 西宁 810000

北京师范大学认知神经科学与学习国家重点实验室,北京 100875

北京师范大学老年脑健康研究中心,北京 100875

展开 >

多模态MRI 参芪益智颗粒 前驱期阿尔茨海默病 高原地区 多维度认知

2024

中风与神经疾病杂志
吉林大学

中风与神经疾病杂志

CSTPCD
影响因子:0.754
ISSN:1003-2754
年,卷(期):2024.41(12)